-
NanOlogy Unveils Drug Development Program for Rare Pediatric Brainstem Tumor
Next Generation Intratumoral Technology Targets Diffuse Intrinsic Pontine Glioma Investigational New Drug Enabling Studies are Underway with Planned Clinical Trial to Begin Late 2026 FORT WORTH, Texas, Dec. 11, 2025 /PRNewswire/ — NanOlogy, LLC, a private clinical-stage oncology company, is pleased to announce its drug development program aimed at transforming the treatment of diffuse intrinsic
-
Give the Gift of Health This Holiday Season with the jscreen jGift
ATLANTA, Dec. 11, 2025 /PRNewswire/ — This holiday season, jscreen introduces the jGift, a simple and meaningful way to give the gift of health. The jGift makes it easy for anyone to share the benefits of genetic testing with family and friends through jscreen.org, a national nonprofit public health initiative providing education, access to genetic testing, and
-
Sen-Jam Pharmaceutical Secures Major Strategic Partnership with TASK Clinical to Fund Two-Thirds of Phase 3 Trial for SJP-001
Equity-backed commitment dramatically de-risks pivotal program, boosts licensing appeal, and strengthens commercialization readiness. HUNTINGTON, N.Y., Dec. 11, 2025 /PRNewswire/ — Sen-Jam Pharmaceutical, a clinical-stage biotechnology company pioneering novel anti-inflammatory combination therapeutics, today announced a transformative partnership with TASK Clinical, a global contract research organization (CRO). Under the agreement, TASK Clinical will fund two-thirds of the
-
Radial Launches with $50 Million to Expand Access to Advanced Brain Medicine
NEW YORK, Dec. 9, 2025 /PRNewswire/ — Radial today announced the company has raised $50 million in venture funding to create access to the world’s most advanced mental health treatments. The company is backed by General Catalyst, who led the Series A, and additional investors Solari Capital, JSL Health Capital, Founder Collective, BoxGroup, Scrub Capital, and
-
OptiMantra-based Online Pharmacies Are Using Alternative Payment Gateways. Here’s Why.
SCARBOROUGH, Maine, Dec. 9, 2025 /PRNewswire/ — A growing number of online pharmacies and telehealth practices that use the popular, well-regarded OptiMantra practice management software are turning to alternative payment gateways as they search for stable, reliable credit card processing. Many providers offering GLP-1 weight-loss prescriptions, virtual care, and online therapy services report that account freezes
-
Mercury Bio Announces Appointment of Casey Perkins as Vice President of Corporate Strategy & Business Development
SANTA FE, N.M., Dec. 9, 2025 /PRNewswire/ — Mercury Bio, a company advancing intracellular delivery for central nervous system (CNS) therapeutics through its proprietary yEV™ platform, is pleased to announce the appointment of Cassandra “Casey” Perkins as Vice President of Corporate Strategy & Business Development. Cassandra "Casey" Perkins joins Mercury Bio Inc. as Vice President of Corporate Strategy
-
Yenos Analytical Launches the Yenos Test, First-of-its-Kind Multi-Cancer Early Detection Urine Test
-Only MCED test to use a urine sample collected at home instead of blood draw.-Only MCED to detect stage I/II cancers with 97% sensitivity and 97% specificity.-Offered as a laboratory-developed test at $749-Nationwide access enabled through FedEx with prepaid shipping both ways. EL DORADO HILLS, Calif., Dec. 9, 2025 /PRNewswire/ — Yenos Analytical LLC, a
-
Sen-Jam Pharmaceutical Appoints Global Life Sciences Leader Rute Fernandes as Executive Advisor to Accelerate Commercialization Pathways
HUNTINGTON, N.Y., Dec. 9, 2025 /PRNewswire/ — Sen-Jam Pharmaceutical, a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics for inflammation-driven conditions, today announced the appointment of Rute Fernandes as Executive Advisor to support commercialization strategy, scenario planning, and launch readiness across the company’s advancing pipeline. Sen-Jam Pharmaceutical Appoints Global Life Sciences Leader Rute Fernandes as Executive Advisor
-
Korea University Researchers Develop Ultrasensitive Method to Detect Low-Frequency Cancer Mutations
SEOUL, South Korea, Dec. 9, 2025 /PRNewswire/ — MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can distinguish single-base mismatches across all sgRNA positions with near-zero off-target activity. By selectively removing wild-type DNA before sequencing, it boosts true mutant signals up to tens of times and enables detection as
-
Pusan National University Study Highlights the Health Hazards of Ultrafine Particles from Small Home Appliances with Electric Heating Coils and Brushed DC Motors
Ultrafine particles emitted from small home appliances with electric heating coils and brushed DC motors cause health hazards BUSAN, South Korea, Dec. 8, 2025 /PRNewswire/ — Indoor air quality has become an urgent concern in recent times, as we spend a considerable amount of time inside our homes. Advances in measurement technologies have revealed that
